RxDoctor Payments Data

Anna Little

Pediatrics · Carbondale, ILNPI 1982801742

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $818, more than ten times the $19 reported in 2019. Among pediatrics clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,811in general payments, 2019–2025

Across 80 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$395
  • AstraZeneca$196
  • Braeburn Inc.$171
  • Exact Sciences$164
  • Indivior Inc.$130
  • AbbVie$128
  • plus $627 from 19 others

What the payments were for

  • Food & beverage$1,811100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,811 in reported general payments places this provider in the 90th percentile of 2,058 pediatrics providers in Illinois.

See all pediatrics providers in Illinois →

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide44$46,166
LinzessLinaclotide24$18,150
JanuviaSitagliptin Phosphate14$13,218
RybelsusSemaglutide13$12,014
MyrbetriqMirabegron11$9,903
FarxigaDapagliflozin Propanediol17$9,874
SymbicortBudesonide/Formoterol Fumarate22$7,219
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,590
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$1,669
Pregabalin48$1,666
Albuterol Sulfate HfaAlbuterol Sulfate49$1,594
Tramadol Hcl60$1,041
Bupropion XlBupropion Hcl19$983
Gabapentin48$972
Atorvastatin Calcium105$878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$18$46,16644 claims
AbbVieLinzess$128$18,15024 claims
AstraZenecaFarxiga, Symbicort$196$17,09339 claims
MerckJanuvia$23$13,21814 claims
Novo NordiskRybelsus$395$12,01413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,058 pediatrics providers in Illinois.

Other pediatrics in Carbondale

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →